News Hub

Real-time financial, economic, and global news with market-focused context and analysis.

Coverage spans equities, macroeconomic data, commodities, currencies, technology, politics, and global events—paired with analysis that highlights why each development matters for traders and investors. From breaking headlines to hourly market snapshots and in-depth articles, the News Hub is designed to help you stay informed, oriented, and ahead of market-moving events.

  • Block cut its AI organization by 40% to reduce costs.
  • The reorg is producing early margin recovery for the company.
  • The restructuring is enabling earlier product monetization from Block's AI efforts.
  • Analysts propose a mid-trade long: entry $68, stop $60, target $85.
  • Trade horizon is about 45 trading days, signaling a short-term upside play.
  • Assessment tilts the risk/reward toward a medium-term long on Block.

Latest Articles

Adobe Expands Saudi Initiative, Pledges Over $4 Billion in AI Access

Adobe Expands Saudi Initiative, Pledges Over $4 Billion in AI Access

Adobe said it will extend its collaboration with Saudi Arabia’s Ministry of Communications and Information Technology and government-backed AI firm Humain to offer one year of no-cost access to key AI tools for more than 27 million eligible Saudi citizens and residents. The program includes a Saudi-focused image generation model developed jointly w…

Buy Verastem: Rare-disease Revenues Fund a KRAS G12D Growth Option

Buy Verastem: Rare-disease Revenues Fund a KRAS G12D Growth Option

Verastem's rare-disease commercial foothold is providing non-dilutive funding and credibility at a time the company needs to advance its KRAS G12D platform. The balance sheet and operational runway are imperfect, but the combination of a revenue stream, manageable enterprise value ($599M), and concentrated short interest creates an asymmetric risk/…

SAIC Shares Jump After Strong Q2 Results and Upgraded Guidance

SAIC Shares Jump After Strong Q2 Results and Upgraded Guidance

Science Applications International Corp. (SAIC) rallied sharply in pre-market trading after reporting second-quarter fiscal 2027 results that outperformed analyst expectations on both earnings and revenue. The Reston, Virginia-based government technology integrator not only posted an adjusted diluted EPS and revenue beat, but also raised its FY2027…

Meta’s Shares Lifted by BofA Reaffirmation and New AI Monetization Signals

Meta’s Shares Lifted by BofA Reaffirmation and New AI Monetization Signals

Meta Platforms shares are trading higher in pre-market action after a Bank of America reiteration and fresh Bernstein forecasts highlighted the company’s potential AI-driven monetization. Reports that Meta plans to deploy a consumer AI agent, codenamed "Hatch," within Instagram and WhatsApp as soon as the first week of September, along with plans f…

Xanadu Charts Path to Over 1,000 Logical Qubits by 2031

Xanadu Charts Path to Over 1,000 Logical Qubits by 2031

Xanadu Quantum Technologies Limited announced a detailed technology roadmap aiming to achieve fault-tolerant quantum computing with over 1,000 logical qubits by 2031. The roadmap focuses on reducing photon loss to enable quantum error correction, scaling hardware architecture, and expanding its PennyLane quantum software platform. The company empha…

Quantum Cyber Completes Purchase and Installation of 80-Unit 3D Printing Drone Production Farm at Its Bridgeport, Connecticut Manufacturing Facility

Quantum Cyber Completes Purchase and Installation of 80-Unit 3D Printing Drone Production Farm at Its Bridgeport, Connecticut Manufacturing Facility

Quantum Cyber N.V. has completed the purchase and installation of an 80-unit 3D Printing drone production farm at its Bridgeport, Connecticut manufacturing facility. This milestone operationalizes the company's primary autonomous drone manufacturing line, supporting multiple drone product lines. The installation aligns with Quantum Cyber's strategy…

Palvella Therapeutics Completes Rolling Submission of New Drug Application to FDA for QTORIN™ Rapamycin for the Treatment of Microcystic Lymphatic Malformations

Palvella Therapeutics Completes Rolling Submission of New Drug Application to FDA for QTORIN™ Rapamycin for the Treatment of Microcystic Lymphatic Malformations

Palvella Therapeutics has completed the rolling submission of its New Drug Application for QTORIN™ 3.9% rapamycin anhydrous gel to the FDA, aiming to secure approval as the first FDA-approved treatment for microcystic lymphatic malformations. This rare genetic disease currently has no approved therapies. The NDA includes robust Phase 3 clinical dat…

SRX Global Acquires Senior Secured Debt in CERo Therapeutics Holdings, Inc., an Innovative Cellular Immunotherapy Company with Cancer Fighting Molecule for the Treatment of Hematologic Cancers

SRX Global Acquires Senior Secured Debt in CERo Therapeutics Holdings, Inc., an Innovative Cellular Immunotherapy Company with Cancer Fighting Molecule for the Treatment of Hematologic Cancers

SRX Global Inc. has purchased senior secured debt in CERo Therapeutics Holdings, providing CERo with additional capital to accelerate clinical development of its engineered T cell therapeutic, CER-1236, which is currently in Phase 1 trials for multiple hematologic cancers. The investment supports CERo's strategy to advance innovative cancer immunot…

Indonesia Energy Announces K-29 Well Drilling Has Reached Total Depth and Testing Operations Are In Preparation

Indonesia Energy Announces K-29 Well Drilling Has Reached Total Depth and Testing Operations Are In Preparation

Indonesia Energy Corporation (NYSE American: INDO) announced that its K-29 well at the Kruh Block has reached total depth of 3,378 feet and is preparing for testing operations. The company will proceed with drilling at the WK-5 wellsite as part of its ongoing exploration program in Indonesia. A live update presentation is scheduled to provide furth…

SAIC Announces Second Quarter of Fiscal Year 2027 Results

SAIC Announces Second Quarter of Fiscal Year 2027 Results

Science Applications International Corporation (SAIC) announced its second quarter fiscal year 2027 results, reporting $1.88 billion in revenues representing approximately 6.3% growth including 5.3% organic growth. Net income was $102 million with adjusted EBITDA of $193 million. Despite some decreases in adjusted diluted EPS compared to the prior …

Premarket: Futures Slip, Oil Jumps as Geopolitical Tensions Rattle Markets; Tenax, Snap Advance, Miniso Slides

Premarket: Futures Slip, Oil Jumps as Geopolitical Tensions Rattle Markets; Tenax, Snap Advance, Miniso Slides

U.S. equity futures opened lower on Monday after new U.S. military strikes on Iranian targets in the Persian Gulf lifted crude prices and after a Fed-related shift toward tighter rate expectations following Federal Reserve Chair Kevin Warsh's Jackson Hole address. Against that backdrop, a handful of companies registered notable premarket swings: Te…

GameStop Flags Lower Q2 Sales as Store Closures and France Exit Weigh

GameStop Flags Lower Q2 Sales as Store Closures and France Exit Weigh

GameStop said it now expects preliminary second-quarter net sales of $780 million to $800 million, down from $972.2 million a year earlier, as planned store closures and the sale of its France operations reduce revenue. The company projects higher quarterly net income driven largely by about $238 million of net gains tied to its eBay derivative ass…

BioMarin Gains After Global Patent Settlement With Ascendis Over Yuviwel

BioMarin Gains After Global Patent Settlement With Ascendis Over Yuviwel

BioMarin Pharmaceutical shares climbed after the company and Ascendis Pharma reached a global settlement ending patent disputes tied to Ascendis’s Yuviwel drug. The accord sets royalty rates for multiple regions, grants licenses covering current and future indications, and settles litigation across several countries as well as a pending Section 337…

Buy the Brunch Dip: First Watch Is Undercooked at $12.50

Buy the Brunch Dip: First Watch Is Undercooked at $12.50

First Watch (FWRG) sold off into a comfortable entry near $12.50 after a run of openings and strong top-line growth. Fundamentals show accelerating unit growth, healthy operating cash flow (~$130M annual), and a manageable balance sheet. The pullback is an opportunity: trade a mid-term long with clear entry, stop and target while watching same-rest…

GDEV announces commencement of self tender offer to purchase for cash up to $20,000,000 in value of its ordinary shares (or up to 1,813,236 Ordinary Shares) at a purchase price of $11.03 per ordinary share

GDEV announces commencement of self tender offer to purchase for cash up to $20,000,000 in value of its ordinary shares (or up to 1,813,236 Ordinary Shares) at a purchase price of $11.03 per ordinary share

GDEV Inc., a NASDAQ-listed gaming and entertainment company, announced a cash tender offer to repurchase up to $20 million worth of its ordinary shares, approximately 1,813,236 shares, at $11.03 per share. The tender offer aims to provide liquidity to shareholders while allowing the company to manage capitalization and deliver value, with shares ac…

Lightbridge Selected for U.S. Department of Energy Launch Pad INL Program to Advance Commercialization of Lightbridge Fuel™

Lightbridge Selected for U.S. Department of Energy Launch Pad INL Program to Advance Commercialization of Lightbridge Fuel™

Lightbridge Corporation announced its selection by the U.S. Department of Energy's Nuclear Energy Launch Pad program at Idaho National Laboratory to build and operate a DOE-authorized facility for producing Lead Test Assemblies of its proprietary metallic nuclear fuel. This marks a significant advancement toward commercial deployment of Lightbridge…